![](/img/cover-not-exists.png)
Tipifarnib Plus Tamoxifen in Tamoxifen-Resistant Metastatic Breast Cancer: A Negative Phase II and Screening of Potential Therapeutic Markers by Proteomic Analysis
Dalenc, F., Doisneau-Sixou, S. F., Allal, B. C., Marsili, S., Lauwers-Cances, V., Chaoui, K., Schiltz, O., Monsarrat, B., Filleron, T., Renee, N., Malissein, E., Meunier, E., Favre, G., Roche, H.Volume:
16
Language:
english
Journal:
Clinical Cancer Research
DOI:
10.1158/1078-0432.ccr-09-1192
Date:
February, 2010
File:
PDF, 277 KB
english, 2010